Cigna Group
XMUN:CGN
Intrinsic Value
The Cigna Group is engaged in the provision of global health services. [ Read More ]
The intrinsic value of one CGN stock under the Base Case scenario is 551.02 EUR. Compared to the current market price of 330.4 EUR, Cigna Group is Undervalued by 40%.
Valuation Backtest
Cigna Group
Run backtest to discover the historical profit from buying and selling CGN stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Cigna Group
Current Assets | 37.4B |
Cash & Short-Term Investments | 8.7B |
Receivables | 17.7B |
Other Current Assets | 10.9B |
Non-Current Assets | 115.4B |
Long-Term Investments | 18B |
PP&E | 4.1B |
Intangibles | 75.1B |
Other Non-Current Assets | 18.2B |
Current Liabilities | 48.7B |
Accounts Payable | 8.6B |
Accrued Liabilities | 10B |
Short-Term Debt | 1.2B |
Other Current Liabilities | 29B |
Non-Current Liabilities | 57.8B |
Long-Term Debt | 28.2B |
Other Non-Current Liabilities | 29.7B |
Earnings Waterfall
Cigna Group
Revenue
|
195.3B
USD
|
Cost of Revenue
|
-170.1B
USD
|
Gross Profit
|
25.2B
USD
|
Operating Expenses
|
-16.1B
USD
|
Operating Income
|
9B
USD
|
Other Expenses
|
-3.9B
USD
|
Net Income
|
5.2B
USD
|
Free Cash Flow Analysis
Cigna Group
CGN Profitability Score
Profitability Due Diligence
Cigna Group's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Cigna Group's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
CGN Solvency Score
Solvency Due Diligence
Cigna Group's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Score
Cigna Group's solvency score is 43/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CGN Price Targets Summary
Cigna Group
Shareholder Return
CGN Price
Cigna Group
Average Annual Return | 21.35% |
Standard Deviation of Annual Returns | 26.64% |
Max Drawdown | -3% |
Market Capitalization | 96.6B EUR |
Shares Outstanding | 292 620 000 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
The Cigna Group is engaged in the provision of global health services. The company is headquartered in Bloomfield, Connecticut and currently employs 71,300 full-time employees. Its portfolio of offerings solves diverse challenges across the healthcare system. The company offers a differentiated set of pharmacy, medical, behavioral, dental, and supplemental products, and services, primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes a range of coordinated and point solution health services and capabilities, as well as those from partners across the health care system, in pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions, which are provided to health plans, employers, government organizations and health care providers. Evernorth Health Services also offers MDLIVE virtual care platform. Cigna Healthcare includes the United States Commercial, United States Government, and International Health operating segments, which provide medical and coordinated solutions to clients and customers.
Contact
IPO
Employees
Officers
The intrinsic value of one CGN stock under the Base Case scenario is 551.02 EUR.
Compared to the current market price of 330.4 EUR, Cigna Group is Undervalued by 40%.